Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Associated Banc-Corp Receives Upward Earnings Revisions from Zacks

Robert Sasse by Robert Sasse
August 19, 2025
in Stocks
0
Associated Banc- Stock
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

Financial research firm Zacks has upgraded its earnings projections for Associated Banc-Corp. The firm now anticipates the company will report a profit of $0.63 per share for the third quarter of 2025, a positive revision from its previous forecast of $0.62 per share. Looking at the full 2025 fiscal year, Zacks’ analysts project earnings will reach $2.43 per share.

This heightened optimism is built upon a foundation of robust second-quarter performance. The bank’s operational strength was clearly demonstrated by its quarterly revenue of $366.98 million and a net interest margin of 5.79%. Most notably, Associated Banc-Corp delivered earnings of $0.65 per share, significantly surpassing market expectations.

Should investors sell immediately? Or is it worth buying Associated Banc-?

Beyond its core operational results, the institution continues to offer value to its shareholders through a reliable dividend. The board has declared a quarterly cash dividend of $0.23 per common share. This payment will be distributed on September 15 to all shareholders of record as of September 2. Based on the current share price, this distribution provides an attractive annualized dividend yield of 3.7%.

Ad

Associated Banc- Stock: Buy or Sell?! New Associated Banc- Analysis from March 25 delivers the answer:

The latest Associated Banc- figures speak for themselves: Urgent action needed for Associated Banc- investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Associated Banc-: Buy or sell? Read more here...

Tags: Associated Banc-
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Life Time Holdings Stock

A Tale of Two Strategies: Institutional Bulls Versus Insider Bears at Life Time Holdings

Monolithic Power Stock

A Tale of Two Signals: Monolithic Power's Record Results Meet Institutional Skepticism

KanzhunADR Stock

Institutional Investors Divided on Kanzhun Ahead of Earnings

Recommended

Analyst Reaffirms Buy Rating and Price Target for Mayville Engineering

2 years ago
Abeona Therapeut. Stock

Abeona Therapeutics Stock Gains Momentum Following ZEVASKYN™ Launch

7 months ago
General Electric Stock

Is GE Aerospace Flying Too Close to the Sun?

5 months ago
Intel Stock

Leadership Shakeup at Intel Signals Strategic Overhaul

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

UnitedHealth Bets on Artificial Intelligence to Counteract Mounting Pressures

A Tale of Two Signals: AppLovin’s Bullish Analysts and Bearish Insiders

Atlassian Shares Hit Fresh Annual Low Amid Sector-Wide Concerns

Institutional Investors Increase Stakes in Healthcare Giant Johnson & Johnson

Qualcomm Launches Major Capital Return Initiative Amid Strategic Shift

Copper’s Critical Role Powers Freeport-McMoRan’s Strategic Expansion

Trending

Rocket Lab USA Stock
Analysis

Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory

by Kennethcix
March 25, 2026
0

Recent analyst coverage updates for Rocket Lab USA have painted a uniformly optimistic picture for the aerospace...

TSMC Stock

TSMC’s Arizona Expansion Gains Momentum Amid Record Retail Investor Interest

March 25, 2026
Salesforce Stock

Salesforce Shares Face Pressure from External AI Innovation

March 25, 2026
Unitedhealth Stock

UnitedHealth Bets on Artificial Intelligence to Counteract Mounting Pressures

March 25, 2026
Applovin Stock

A Tale of Two Signals: AppLovin’s Bullish Analysts and Bearish Insiders

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory
  • TSMC’s Arizona Expansion Gains Momentum Amid Record Retail Investor Interest
  • Salesforce Shares Face Pressure from External AI Innovation

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com